Ophthalmology · Brooklyn, NY
NPI
1063415537
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2965 Ocean Pkwy, Ste 4
Brooklyn, NY, 11235
Phone (718) 333-2020
Medicare paid, 2024
$1.7M
15,991 services
Medicare patients, 2024
1,507
Average age 79
Drug cost, 2024
$3.8M
14,724 prescriptions
Company payments, 2025
$2,396
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ilona Genis was code 99213 (office e&m - established), 2,517 times for 991 patients. In total Ilona Genis billed 15,991 services in 68 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,517 | 991 | $83.53 | $210K |
| 92083 Vision, Hearing, and Speech Services | Office | 1,525 | 1,188 | $57.85 | $88K |
| 92250 Angiography | Office | 1,470 | 1,144 | $32.78 | $48K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,139 | 746 | $32.82 | $37K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,037 | 508 | $37.10 | $38K |
| J0178 Injection, aflibercept, 1 mg | Office | 740 | 77 | $656.63 | $486K |
| 99212 Office E&M - Established | Office | 703 | 377 | $53.68 | $38K |
| 76513 Ultrasound - Nonspecific | Office | 694 | 601 | $133.51 | $93K |
| 67028 Intravitreal Injection | Office | 689 | 110 | $106.46 | $73K |
| 68761 Eye | Office | 482 | 284 | $207.12 | $100K |
| 76512 Ultrasound - Nonspecific | Office | 436 | 330 | $62.51 | $27K |
| 92286 Standard X-ray | Office | 417 | 398 | $35.21 | $15K |
| 92014 Ophthalmological E&M | Office | 369 | 359 | $116.84 | $43K |
| 92004 Ophthalmological E&M | Office | 334 | 334 | $138.25 | $46K |
| J9035 Injection, bevacizumab, 10 mg | Office | 265 | 67 | $56.94 | $15K |
By year: 2022 $1.5M for 13,681 services; 2023 $1.6M for 14,511 services; 2024 $1.7M for 15,991 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ilona Genis prescribed most often to Medicare patients was Latanoprost, with 1,313 prescriptions and refills. In total Ilona Genis wrote 14,724 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,313 | 2,076 | 244 | $8,879 |
| Lumigan Bimatoprost | 1,043 | 1,486 | 184 | $397K |
| Prolensa Bromfenac Sodium | 927 | 1,045 | 223 | $321K |
| Vyzulta Latanoprostene Bunod | 714 | 985 | 120 | $272K |
| Miebo Perfluorohexyloctane/Pf | 638 | 667 | 202 | $495K |
| Erythromycin Erythromycin Base | 582 | 582 | 238 | $5,032 |
| Azelastine Hcl Generic | 577 | 711 | 136 | $8,767 |
| Timolol Maleate Generic | 573 | 1,085 | 116 | $13K |
| Brimonidine Tartrate Generic | 571 | 943 | 155 | $46K |
| Restasis Cyclosporine | 565 | 749 | 121 | $462K |
| Prednisolone Acetate Generic | 535 | 756 | 244 | $22K |
| Ketorolac Tromethamine Generic | 504 | 785 | 193 | $7,877 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 488 | 532 | 75 | $165K |
| Dorzolamide Hcl Generic | 466 | 708 | 97 | $5,846 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 454 | 765 | 83 | $6,491 |
Brand drugs: 8,502 claims; generic drugs: 6,222 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ilona Genis $2,396 ($2,396 in general payments such as food, travel and fees) from 14 companies. The largest payer was Bausch & Lomb Americas Inc. with $513.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 15 | $513 |
| Harrow Eye, LLC | 13 | $362 |
| Abbvie Inc. ABBV | 13 | $345 |
| Alcon Vision LLC ALC | 8 | $225 |
| Tarsus Pharmaceuticals, Inc. TARS | 8 | $223 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $157 |
| Dompe US, Inc. | 4 | $101 |
| Apellis Pharmaceuticals, Inc. APLS | 3 | $98.63 |
| Mallinckrodt Hospital Products Inc. | 3 | $89.01 |
| Astellas Pharma US Inc 4503.T | 3 | $79.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.